rs199886454
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_021005.4(NR2F2):c.834G>A(p.Ser278Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000713 in 1,613,970 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00068 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00072 ( 11 hom. )
Consequence
NR2F2
NM_021005.4 synonymous
NM_021005.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.419
Genes affected
NR2F2 (HGNC:7976): (nuclear receptor subfamily 2 group F member 2) This gene encodes a member of the steroid thyroid hormone superfamily of nuclear receptors. The encoded protein is a ligand inducible transcription factor that is involved in the regulation of many different genes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 15-96334467-G-A is Benign according to our data. Variant chr15-96334467-G-A is described in ClinVar as [Benign]. Clinvar id is 413760.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.419 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000676 (103/152324) while in subpopulation SAS AF= 0.0143 (69/4826). AF 95% confidence interval is 0.0116. There are 1 homozygotes in gnomad4. There are 66 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 103 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR2F2 | NM_021005.4 | c.834G>A | p.Ser278Ser | synonymous_variant | Exon 2 of 3 | ENST00000394166.8 | NP_066285.1 | |
NR2F2 | NM_001145155.2 | c.435G>A | p.Ser145Ser | synonymous_variant | Exon 2 of 3 | NP_001138627.1 | ||
NR2F2 | NM_001145156.1 | c.375G>A | p.Ser125Ser | synonymous_variant | Exon 2 of 3 | NP_001138628.1 | ||
NR2F2 | NM_001145157.2 | c.375G>A | p.Ser125Ser | synonymous_variant | Exon 2 of 3 | NP_001138629.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000683 AC: 104AN: 152206Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
104
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00147 AC: 368AN: 250724Hom.: 5 AF XY: 0.00204 AC XY: 277AN XY: 135694
GnomAD3 exomes
AF:
AC:
368
AN:
250724
Hom.:
AF XY:
AC XY:
277
AN XY:
135694
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000717 AC: 1048AN: 1461646Hom.: 11 Cov.: 32 AF XY: 0.00103 AC XY: 750AN XY: 727134
GnomAD4 exome
AF:
AC:
1048
AN:
1461646
Hom.:
Cov.:
32
AF XY:
AC XY:
750
AN XY:
727134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000676 AC: 103AN: 152324Hom.: 1 Cov.: 33 AF XY: 0.000886 AC XY: 66AN XY: 74482
GnomAD4 genome
AF:
AC:
103
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
66
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Congenital heart defects, multiple types, 4 Benign:1
Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
Oct 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
NR2F2: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at